Your account is not claimed yet. You can sign up with ORCID to claim your account.

Brendan J Jenkins

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Oncogene

International journal of cancer

Nature reviews. Cancer

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed I Saad, Brendan J Jenkins
The Protease ADAM17 at the Crossroads of Disease: Revisiting its Significance in Inflammation, Cancer, and Beyond. The FEBS journal (2023)
Stefan Rose-John, Brendan J Jenkins, Christoph Garbers, Jens M Moll, Jürgen Scheller
Targeting IL-6 trans-signalling: past, present and future prospects. Nature reviews. Immunology (2023)
Si Ming Man, Brendan J Jenkins
Context-dependent functions of pattern recognition receptors in cancer. Nature reviews. Cancer 22 (7) (2022)
Ruby E Dawson, Virginie Deswaerte, Alison C West, Ke Tang, Alice J West, Jesse J Balic, Linden J Gearing, Mohamed I Saad, Liang Yu, Yonghui Wu, Prithi S Bhathal, Beena Kumar, Jayati T Chakrabarti, Yana Zavros, Hiroko Oshima, Dennis M Klinman, Masanobu Oshima, Patrick Boon-Ooi Tan, Brendan J Jenkins
STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis. Gut (2021)
Sultan Alhayyani, Louise McLeod, Alison C West, Jesse J Balic, Christopher Hodges, Liang Yu, Julian A Smith, Zdenka Prodanovic, Steven Bozinovski, Beena Kumar, Saleela M Ruwanpura, Mohamed I Saad, Brendan J Jenkins
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer. Oncogene (2021)
Liang Yu, Can Cao, Xu Li, Mili Zhang, Qisheng Gu, Hugh Gao, Jesse J Balic, Duogang Xu, Lei Zhang, Le Ying, Dakang Xu, Yuqin Yang, Di Wu, Baokun He, Brendan J Jenkins, Youdong Liu, Jikun Li
Complete loss of miR-200 family induces EMT associated cellular senescence in gastric cancer. Oncogene (2021)
Joanne Lundy, Linden J Gearing, Hugh Gao, Alison C West, Louise McLeod, Virginie Deswaerte, Liang Yu, Sean Porazinski, Marina Pajic, Paul J Hertzog, Daniel Croagh, Brendan J Jenkins
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma. Oncogene 40 (41) (2021)
Mohamed I Saad, Sultan Alhayyani, Louise McLeod, Liang Yu, Mohammad Alanazi, Virginie Deswaerte, Ke Tang, Thierry Jarde, Julian A Smith, Zdenka Prodanovic, Michelle D Tate, Jesse J Balic, D Neil Watkins, Jason E Cain, Steven Bozinovski, Elizabeth Algar, Tomohiro Kohmoto, Hiromichi Ebi, Walter Ferlin, Christoph Garbers, Saleela Ruwanpura, Irit Sagi, Stefan Rose-John, Brendan J Jenkins
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer. EMBO molecular medicine 11 (4) (2020)
You Dong Liu, Liang Yu, Le Ying, Jesse Balic, Hugh Gao, Nian Tao Deng, Alison West, Feng Yan, Cheng Bo Ji, Daniel Gough, Patrick Tan, Brendan J Jenkins, Ji Kun Li
Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2. International journal of cancer 144 (12) (2019)
David G Hill, Liang Yu, Hugh Gao, Jesse J Balic, Alison West, Hiroko Oshima, Louise McLeod, Masanobu Oshima, Awen Gallimore, Kimberley D'Costa, Prithi S Bhathal, William Sievert, Richard L Ferrero, Brendan J Jenkins, Gareth W Jones
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development. International journal of cancer 143 (1) (2018)
William Berry, Elizabeth Algar, Beena Kumar, Christopher Desmond, Michael Swan, Brendan J Jenkins, Daniel Croagh
Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors. International journal of cancer 140 (10) (2017)

Brendan J Jenkins.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Brendan J Jenkins